Surgeons in China have successfully transplanted a genetically modified pig lung into a brain-dead human for the first time, with the organ functioning for nine days. The research, published in Nature Medicine, represents a significant advance in xenotransplantation, a field aimed at addressing the global shortage of donor organs. According to the World Health Organization, only about 10% of the need for transplants worldwide is currently being met.
The lung came from a Chinese Bama Xiang pig with six genetic modifications designed to reduce rejection by the human immune system. It was implanted into a 39-year-old brain-dead male recipient, where it remained viable for 216 hours without triggering hyperacute rejection or infection. However, fluid accumulation and antibody-related damage occurred over time, despite powerful immunosuppressive treatment. Experts note that the recipient’s remaining natural lung likely masked the full impact of the transplant’s deterioration.
Challenges of Lung Xenotransplantation
While pig hearts, kidneys, and livers have been successfully transplanted into humans, lungs present unique difficulties. “Every breath brings the external environment into the body,” explained Andrew Fisher, professor of respiratory transplant medicine at Newcastle University. This makes the lungs’ immune system highly sensitive, increasing the risk of rejection and complications. Peter Friend from the University of Oxford added that brain death itself causes inflammation, complicating the interpretation of results.
Looking Ahead
Researchers stressed that more work is needed to optimize immunosuppressive regimens, refine genetic modifications, and improve organ preservation to ensure long-term viability. Other strategies to expand organ availability include reconditioning human donor lungs, growing humanized organs in pigs or sheep, and using stem cells to remodel organs.
Experts caution that while this experiment is promising, it represents only an incremental step toward clinically viable pig lung transplants. Short-term success in a brain-dead recipient does not yet indicate readiness for living patients. Still, xenotransplantation remains a hopeful avenue for addressing the persistent global organ shortage.
